spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  SCHWARZ PHARMA 

 HSMN NewsFeed - 22 Mar 2016
First FDA-Approved Medicine Manufactured Using 3D Printing Technology Now Available
Biopharmaceuticals Drug Delivery Neurology Product Launch
 HSMN NewsFeed - 23 Jun 2014
Versartis Appoints Endocrinologist Bert Bakker, MD, PhD, as Senior Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2014
Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2008
Cambridge Laboratories Announces Approval of Tetrabenazine in Spain
Biopharmaceuticals Reimbursement Distribution
 HSMN NewsFeed - 6 Oct 2008
Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron(R) in Hepatitis C
Biopharmaceuticasl Venture Capital
 HSMN NewsFeed - 22 Sep 2008
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Apr 2008
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Mar 2008
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
Biopharmaceuticals Neurology Product Recall
 HSMN NewsFeed - 4 Mar 2008
UCB: Early Data on Cimzia(R) from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 3 Mar 2008
Changes in UCB's Executive Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2008
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2008
FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Dec 2007
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Dec 2007
UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Dec 2007
UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Nov 2007
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 12 Nov 2007
Cumberland Pharmaceuticals Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2007
UCB Announces Initiation of Phase III Clinical Program for RikeltaTM (brivaracetam) as Adjunctive Treatment in Partial-Onset Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 8 Oct 2007
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 17 Aug 2007
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2007
Pivotal CIMZIA(TM) Data in Crohn's Disease Published in New England Journal of Medicine
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 16 Jul 2007
UCB Announces the U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jul 2007
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 May 2007
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2007
UCB Presents Long-Term CIMZIA(TM) Data in Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 10 May 2007
FDA Approves SCHWARZ PHARMA's Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 20 Apr 2007
UCB Announces Positive Top-Line Phase III Results for Keppra(R) as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Apr 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Mar 2007
UCB Provides Update on CIMZIA(TM) for Crohn's Disease and Rheumatoid Arthritis in the US
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 20 Mar 2007
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Mar 2007
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Mar 2007
Teva Receives First U.S. Approval for Generic Uniretic(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Jan 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data in Neurology
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 8 Nov 2006
Napo Pharmaceuticals, Inc. ("Napo" or "the Company") Appointment of VP Clinical Affairs and Chief Medical Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 28

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 28 additional stories matching:
SCHWARZ PHARMA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.